Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Recruiting1
Other3

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT07031765Phase 1Active Not Recruiting
Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
EpendymomaGrade III AstrocytomaGrade IV Astrocytoma+3 more
PrincipalinvestigatorStart date: 2025-07-25
NCT06514898Phase 1Recruiting
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
PrincipalinvestigatorStart date: 2025-05-05
NCT05660408Phase 1/2Active Not Recruiting
RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors
Recurrent High-grade GliomaRecurrent Pulmonary Osteosarcoma
StudychairStart date: 2025-03-12

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Duane Mitchell, MD, PhD

University of Florida

Moderately Similar
5 trials

Shared therapeutic areas:

GlioblastomaRecurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Worked with same sponsors:

Children's National Research InstituteNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score34%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaGlioblastoma+1 more
Similarity Score11%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaEpendymoma
Similarity Score8%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaEpendymoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Anaplastic AstrocytomaEpendymomaOligodendroglioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Daniel Landi, MD

Duke University

Related
7 trials

Shared therapeutic areas:

GlioblastomaAnaplastic AstrocytomaEpendymoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEpendymomaGlioblastoma

Worked with same sponsors:

St. Baldrick's FoundationThe V Foundation for Cancer Research
Similarity Score8%

Jaymes Holland

Alaunos Therapeutics

Related
8 trials

Shared therapeutic areas:

GlioblastomaDiffuse Intrinsic Pontine Glioma
Similarity Score5%

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GlioblastomaAnaplastic Astrocytoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Ronald E Gress, M.D.

National Cancer Institute (NCI)

Related
10 trials

Shared therapeutic areas:

Anaplastic AstrocytomaOligodendroglioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07031765Phase 1PrincipalInvestigator

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

EpendymomaGrade III AstrocytomaGrade IV Astrocytoma+3 more
Active Not Recruiting
NCT06514898Phase 1PrincipalInvestigator

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
Recruiting
NCT05660408Phase 1/2StudyChair

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

Recurrent High-grade GliomaRecurrent Pulmonary Osteosarcoma
Active Not Recruiting
NCT06946680Phase 1PrincipalInvestigator

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

Diffuse Intrinsic Pontine GliomaHigh-grade Glioma
Not Yet Recruiting

All 4 trials loaded